AstraZeneca provides update on brodalumab development programme
- Details
- Category: AstraZeneca

Novartis drug Afinitor® extended progression-free survival in Phase III trial in advanced gastrointestinal or lung neuroendocrine tumors
- Details
- Category: Novartis

Boehringer Ingelheim acquires Pharmaxis' phase 1 anti-inflammatory drug candidate
- Details
- Category: Boehringer Ingelheim

AstraZeneca to invest in new biologics manufacturing facility in Södertälje, Sweden
- Details
- Category: AstraZeneca

AstraZeneca and Montreal Heart Institute to screen 80,000 samples for cardiovascular and diabetes genetic traits
- Details
- Category: AstraZeneca

Pfizer acquires minority interest in AM-Pharma; secures option to acquire company
- Details
- Category: Pfizer

Xarelto® approved in China across three indications in the area of venous and arterial thromboembolism
- Details
- Category: Bayer

More Pharma News ...
- Kåre Schultz appointed new president and CEO of Lundbeck
- Strong start to the year for Bayer
- FDA grants Priority Review for potential new indication for Brilinta
- Boehringer Ingelheim positioned for future growth with product launches
- AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology
- Roche reports strong sales growth in the first quarter of 2015
- United States first country to launch Saxenda®